Evaluation of etanercept dose reduction in patients with rheumatoid arthritis using pharmacokinetic/pharmacodynamic modeling and simulation

依那西普 加药 医学 类风湿性关节炎 药效学 药代动力学 药理学 内科学 曲线下面积
作者
Li-Feng Hsu,Jin‐ding Huang
出处
期刊:International Journal of Clinical Pharmacology and Therapeutics [Dustri-Verlag Dr. Karl Feistle]
卷期号:52 (09): 776-786 被引量:3
标识
DOI:10.5414/cp202131
摘要

In this study, we attempt to explore the feasibility of alternative dosing regimens of etanercept in patients with rheumatoid arthritis (RA) using pharmacokinetic/pharmacodynamic (PK/PD) modeling and simulation.All data used for estimation of PK/PD model parameters were collected from previously published literatures. American College of Rheumatology (ACR) 20/50/70 response rate and a disease activity score in 28 joints (DAS28) was selected as the principal clinical endpoint for further PK/PD modeling. The cumulative AUC (area under the concentration-time curve) of etanercept for different dosing regimens was calculated based on the final PK model and was then linked to the time course of clinical endpoints. Ten different dosing regimens were simulated in this study.The PK model that best fit the serum concentration-time data for etanercept was a one-compartment model with first order absorption and elimination. Based on the PK/PD analysis, the relationship between the predicted cumulative AUC of etanercept to the ACR 20/50/70 response rate and DAS28 score was well characterized by Emax logistic and inhibitory Emax model, respectively. In our simulations, the following dosing regimens that are equally effective to current recommended dosage of 25 mg twice weekly (b.i.w.): (1) 25 mg once weekly (q.w.); (2) 50 mg every 2 weeks (q2w); (3) 25 mg b.i.w. for 3 months and 25 mg q2w thereafter; and (4) 50 mg q.w. for 3 months and 50 mg q2w thereafter.In this study, the clinical data was well described by the models developed, and several alternative dosing regimens were proposed. Further clinical studies in patients are still needed to confirm our findings.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Daniel完成签到,获得积分10
刚刚
于芋菊完成签到,获得积分0
刚刚
刚刚
刚刚
2秒前
淙淙完成签到,获得积分10
5秒前
5秒前
7秒前
医小邦完成签到 ,获得积分10
8秒前
9秒前
Wind发布了新的文献求助10
9秒前
10秒前
11秒前
12秒前
abao发布了新的文献求助10
12秒前
榆木先生完成签到 ,获得积分10
12秒前
NJQ完成签到,获得积分10
14秒前
科研能发布了新的文献求助10
14秒前
haloucheng发布了新的文献求助10
15秒前
kkk完成签到,获得积分10
15秒前
16秒前
16秒前
canjian1943发布了新的文献求助10
17秒前
星星发布了新的文献求助10
17秒前
wg发布了新的文献求助10
19秒前
1111完成签到,获得积分20
21秒前
mike完成签到,获得积分10
22秒前
个性的紫菜应助canjian1943采纳,获得10
23秒前
haloucheng完成签到,获得积分10
24秒前
紫金之巅完成签到 ,获得积分10
24秒前
科研能完成签到,获得积分10
25秒前
Macro完成签到 ,获得积分10
29秒前
青青河边草完成签到 ,获得积分10
30秒前
明理的慕蕊完成签到,获得积分10
30秒前
小仙女发布了新的文献求助10
31秒前
judy完成签到,获得积分10
32秒前
34秒前
35秒前
米团发布了新的文献求助30
37秒前
Zeeki完成签到 ,获得积分10
38秒前
高分求助中
Sustainability in Tides Chemistry 2800
The Young builders of New china : the visit of the delegation of the WFDY to the Chinese People's Republic 1000
юрские динозавры восточного забайкалья 800
English Wealden Fossils 700
Foreign Policy of the French Second Empire: A Bibliography 500
Chen Hansheng: China’s Last Romantic Revolutionary 500
XAFS for Everyone 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3143739
求助须知:如何正确求助?哪些是违规求助? 2795236
关于积分的说明 7813804
捐赠科研通 2451222
什么是DOI,文献DOI怎么找? 1304353
科研通“疑难数据库(出版商)”最低求助积分说明 627221
版权声明 601400